AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Aeffe

Regulatory Filings Feb 2, 2018

4140_rns_2018-02-02_68db02f8-cef6-4c11-b117-a37b211205b5.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Informazione
Regolamentata n.
0923-2-2018
Data/Ora Ricezione
02 Febbraio 2018
14:32:57
MTA - Star
Societa' : AEFFE
Identificativo
Informazione
Regolamentata
: 98704
Nome utilizzatore : AEFFEN02 - Degano
Tipologia : REGEM
Data/Ora Ricezione : 02 Febbraio 2018 14:32:57
Data/Ora Inizio
Diffusione presunta
: 02 Febbraio 2018 14:32:58
Oggetto : 2018 Financial calendar update
Testo del comunicato

Vedi allegato.

UPDATE OF 2018 FINANCIAL CALENDAR

The meeting of the Board of Directors to approve FY 2017 Consolidated sales has been anticipated to February 6th, 2018

Aeffe Spa informs that the Board of Directors to approve FY 2017 consolidated sales has been anticipated to February 6th 2018 rather than on February 14th as communicated in December 2017.

2018 FINANCIAL CALENDAR

Dear Analyst, Investor

We would like to communicate you the dates of the Aeffe's 2018 Financial Calendar:

February 6th 2018: Board of Directors approves Aeffe Group Net Sales 2017 results

March 8th 2018: Board of Directors approves the draft of annual consolidated results (31st December 2017) and relative conference call;

April 12th 2018: Annual Shareholders' Meeting approves annual consolidated results (31st December 2017);

May 10th 2018: Board of Directors approves 1Q 2018 consolidated results and relative conference call; July 27th 2018: Board of Directors approves 1H 2018 consolidated results and relative conference call; November 8th 2018: Board of Directors approves 3Q 2018 consolidated results and relative conference call.

For further information do not hesitate to contact myself directly.

Best Regards

Annalisa Aldrovandi Investor Relations Officer Tel. 39 0541 965494 Fax. 39 0541 959009 Email: [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.